Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-21 | Amneal Pharmaceuticals, Inc. | Daly Jason B.
(SVP, Chief Legal Officer) |
S | Class A Common Stock | D | 13665 | $8.40 - $8.40 | $114,786 |
| 2024-11-15 | Amneal Pharmaceuticals, Inc. | Daly Jason B.
(SVP, Chief Legal Officer) |
S | Class A Common Stock | D | 43657 | $8.61 - $8.61 | $375,886 |
| 2024-08-14 | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S
(Executive Vice President) |
S | Class A Common Stock | D | 62711 | $7.81 - $7.85 | $491,381 |
| 2024-08-14 | Amneal Pharmaceuticals, Inc. | Shah Nikita
(Executive Vice President) |
S | Class A Common Stock | D | 100000 | $7.75 - $7.75 | $775,000 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |